Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,327

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,859

Class I recallsReasonable probability of serious health consequences

24,440

Class II recallsTemporary or medically reversible health consequences

2,900

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/imperio-distribution-llc-recalls-beef-jerky-products-produced-without-benefitPublished October 24, 2026

Most affected stateHawaii 200 recalls mention this state

State: LA ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 26, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

FDA Recall TerminatedTerminated: October 11, 2024Historical recordClass II

Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
Published: April 28, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 11, 2024Historical recordClass II

Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
Published: April 28, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 11, 2022Historical recordClass II

Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178

by Edge Pharma, LLC

Reason: Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Published: April 28, 2021
Distribution: Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass I

Real Water, Inc.

Product: Real Alkalized Water, concentrate. 4 oz. glass bottle . Dri…
Reason: FDA was notified of cases of acute liver failure after consumption of Real Water
Published: April 28, 2021
Distribution: Nationwide

View recall →

FDA Recall United States OngoingHistorical recordClass I

Real Water, Inc.

Product: Real Alkalized Water, packed in 16.9 oz., 1 Liter, 1.5 Liter…
Reason: FDA was notified of cases of acute liver failure after consumption of Real Water
Published: April 28, 2021
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 13, 2021Historical recordClass II

Snak King Corporation

Product: Trader Joe's Restaurant Style White Corn Tortilla Chips; Net…
Reason: White Corn Tortilla Chips may contain undeclared milk
Published: April 28, 2021
Distribution: One customer with locations in AL, AZ, A…

View recall →

FDA Recall United States TerminatedTerminated: April 28, 2021Historical recordClass III

Avanti Frozen Foods Private Limited

Product: 365 Whole Foods Market Farm Raised Cooked Shrimp 2 lbs/Ready…
Reason: One lot of uncooked shrimp was inadvertently packaged as cooked shrimp.
Published: April 28, 2021
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 19, 2021Historical recordClass II

Tropicana Products, Inc.

Product: KeVita Cucumber Rosemary (primary package), 15.2 oz., glass…
Reason: Firm initiated a recall because of mislabeling of bottled product inside case.
Published: April 28, 2021
Distribution: The product was disturbed to the various…

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, SAMPLE, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2911-90 (Pen) NDC 0169-2911-97 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass II

ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not for Resale, Rx only, Manufactured by: Novo Nordisk A/S, Bagesvaerd, Denmark NDC 0169-4060-90 (Pen), 0169-4060-99 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

TRESIBA FlexTouch (insulin degludec injection) 200 units/mL (U-200), 3 mL Prefilled Pen, Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2550-90 (Pen), 0169-2550-97 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

TRESIBA (insulin degludec injection) 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-2662-90

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

TRESIBA FlexTouch (insulin degludec injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Movo Mordisk Inc., Plainsboro, NJ 08536, NDC 0169-2660-90 (Pen), NDC 0169-2660-97 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass II

Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-2800-90 (Pen), NDC 0169-2800-97 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass II

OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen, Sample. Not for Resale, Rx only, Novo Nordisk Inc, Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-4132-90 (Pen), NDC 0169-4132-97 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6339-90 (Pen), NDC 0169-6339-98 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

Levemir FlexTouch (insulin detemir) injection, 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6438-90 (Pen), NDC 0169-6438-98 (Kit)

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-3201-90

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 9, 2022Historical recordClass I

Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges per package, Sample Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-3205-91

by Novo Nordisk Inc

Reason: Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Published: April 21, 2021
Distribution: Nationwide

View recall →

Data last updated: October 26, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.